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sis using mouse models and used 2-D gel electrophoresis to
resolve the Candida tropicalis proteome. This would enable
us to identify the useful biomarkers for diagnosis and ther-
apeutic monitoring. The Candida tropicalis proteome was
separated by 2-D electrophoresis using an immobilized, lin-
ear pH 4-7 gradient strip for isoelectric focusing and 12.5%
SDS-polyacrylamide gels for the second dimension separa-
tion. Subsequently, the gel was either stained with silver
nitrate for analysis using PD Quest or electroblotted to PVDF
membranes. Sera from ﬁfteen mice were individually blot-
ted in immunoblotting and the images were captured using
chemiluminescence. Immunoreactive protein spots of inter-
est will then be excised from the silver stained preparative
2-D gels, in-gel destained, reduced, alkylated, digested with
tryspin and ﬁnally sent for MALDI-TOF analysis. N-terminal
amino acid sequencingmay be conducted to identify the pro-
teins and bioinformatics will be used to identify the protein
candidates and their corresponding gene sequences. Hence,
it is hoped that this new strategy can be used to improve the
chances of ﬁnding novel biomarkers that are truly effective
and speciﬁc for Candida tropicalis virulence.
doi:10.1016/j.ijid.2008.05.438
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Most investigations of cerebral malaria pathogenesis have
primarily examined the immune processes relatively late
in an infection initiated by inoculation of parasitized ery-
throcytes. Whereas, natural exposure to malaria infection
occurs via the bite of a Plasmodium-infected Anopheles
mosquito, inoculating the sporozoite stage of the par-
asite predominantly in intradermal spaces. Importantly,
mosquito saliva has demonstrated pharmacologic activity,
and it is becoming clear that mosquito saliva alters the
initial immune environment of an invading pathogen. The
effect of mosquito saliva may be of paramount importance,
as recent research demonstrates that the protective anti-
sporozoite CD8+ T-cell response originates predominantly
from cutaneous lymph nodes. Experiments in our laboratory
have shown that following non-infectious mosquito bites,
the saliva of Anopheles stephensi induces a rapid degranu-
lation of cutaneous mast cells, an inﬂux of neutrophils into
the site of feeding, and a down-regulation of subsequent
T cell-mediated immune responses. Plasmodium berghei
infection initiated in the presence of mosquito saliva led
to elevated expression of interleukin (IL)-4 (1230% and 772%
at 6 and 48 hpi, respectively; p < 0.05) and IL-10 (196% at
6 hpi; p < 0.05) in draining lymph nodes with corresponding
differences observed in the dermal inoculation site. Early
parasitemia was elevated by 1 to 2.8-fold and progression to
cerebral malaria occurs at a higher rate and more rapidly in
mice exposed to An. stephensi feeding prior to inoculation of
sporozoites (2× 103—15× 103). Continuing research is eval-
uating the effect of mosquito saliva in cell migration and
sporozoite motility. Understanding the early events in nat-
ural transmission of the Plasmodium parasite to a host as it
relates to the host response, the perturbance caused by fac-
tors in mosquito saliva, and the reaction of the sporozoite,
may allow for development of novel techniques to amplify
the protective effects of future vaccines and treatments.
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Background: Pathogens such as inﬂuenza viruses stimu-
late a cytokine storm or hypercytokinaemia that contributes
to fatality from the disease. Our group has already shown
that in inﬂuenza A virus-infected mice (A/Japan/305/57)
treated with the lipid-loweringmedication gemﬁbrozil, mor-
tality is halved by gemﬁbrozil treatment. We have now
extended this ﬁnding to another ﬁbrate, fenoﬁbrate, and
have shown that it too, reduces the mortality of severe
murine inﬂuenza. Effects of the statin simvastatin were also
examined.
Methods: Female BALB/c mice, 6 weeks old, were
anaesthetised with avertin and infected with 50 HAU of
H2N2 (A/Japan/305/57) inﬂuenza A virus via intranasal
instillation. Mice were given fenoﬁbrate (45mg/kg, as
a suspension in 0.5% carboxymethylcellulose in saline),
gemﬁbrozil (60mg/kg, in propylene glycol) or simvastatin
(0.2mg/kg, solubilised in ethanol and diluted in endotoxin-
free saline), from days 4—10 post-infection (p.i.). In all
experiments injections of drugs were given by the intraperi-
toneal route, and mock-treated control mice received the
vehicle alone.
Results: Mock-treated mice succumbed to inﬂuenza
virus infection (0% survival), while fenoﬁbrate treatment
increased the percentage of mice surviving to about 30%.
Gemﬁbrozil treatment reliably produced a similar effect
on survival. Simvastatin had no effect on the course of
infection, and the vehicle alone (saline) had a protective
effect. We propose that further experiments are required
to determine the correct dosage and timing for simvastatin
treatment.
Conclusions: Fibrates may prove useful as adjuncts to
antivirals in a future inﬂuenza pandemic. Further, they may
serve as inﬂuenza treatments in their own right, either alone
or when combined with other generic medications.
doi:10.1016/j.ijid.2008.05.440
